Abstract Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in
breast cancer, has limited value for treatment decisions due to questionable analytical …

Pathology is the cornerstone of cancer care. The need for accuracy in histopathologic
diagnosis of cancer is increasing as personalized cancer therapy requires accurate …

PURPOSE To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …

The increasing prevalence of digitised workflows in diagnostic pathology opens the door to
life-saving applications of artificial intelligence (AI). Explainability is identified as a critical …

Purpose.—To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …

PURPOSE To our knowledge, WSG-ADAPT-HR+/HER2–(ClinicalTrials. gov identifier:
NCT01779206; n= 5,625 registered) is the first trial combining the 21-gene expression …

The convergence of digital pathology and computer vision is increasingly enabling
computers to perform tasks performed by humans. As a result, artificial intelligence (AI) is …

Ki67 has potential clinical importance in breast cancer but has yet to see broad acceptance
due to inter-laboratory variability. Here we tested an open source and calibrated automated …

Simple Summary Cellular proliferation is a central determinant of breast cancer recurrence
risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes …

Digital pathology and image analysis potentially provide greater accuracy, reproducibility
and standardisation of pathology‐based trial entry criteria and endpoints, alongside …